Loading organizations...
§ Private Profile · Exton, PA, USA
Supplier of surgical instruments and repair services for hospitals, surgery centers, and surgeons, specializing in ophthalmic, ENT, plastic surgery.
Ambler has raised $10.7M across 3 funding rounds.
Key people at Ambler.
Ambler has raised $10.7M in total across 3 funding rounds.
Founded in 1997 by Marty Anthony, Ambler Surgical is an Exton, Pennsylvania direct supplier of specialty surgical instruments, medical accessories, and equipment repair services. Led by Anthony and Vice President Tony Kroboth, the company provides high-quality alternatives to original equipment manufacturers, specializing in precision instruments for ophthalmic, plastic, neurological, cardiovascular, and otolaryngology surgical procedures. Operating through a B2B e-commerce model, the enterprise maintains an extensive online catalog of over 12,000 products to serve independent surgeons, hospitals, and ambulatory surgery centers nationwide. Supported by approximately 21 to 50 employees, the privately held firm generates an estimated $9.1 million in annual revenue and operates with an estimated valuation of $29.3 million. To expand its market reach within the broader medical device sector, the organization secures strategic group purchasing contracts with major healthcare networks like MAGNET and Premier.
Ambler has raised $10.7M in total across 3 funding rounds.
Ambler's investors include Entrepreneur First, Adrien Neel, Idinvest Partners, Kima Ventures, Partech, Louis B.
Ambler Brook is a thesis-oriented private equity firm specializing in founder-owned businesses within Healthcare and B2B sectors, targeting North American companies with under $15M in EBITDA across services and technology.[1][2][4] The firm's mission centers on partnering with founders and management to implement tailored value creation strategies that drive long-term organic and M&A growth in the lower middle market.[1] Its investment philosophy emphasizes thesis-driven approaches, leveraging three decades of experience from top firms like Candescent Partners, Solamere Capital, and Thomas H. Lee Partners to build market-leading enterprises.[1]
In the startup and growth ecosystem, Ambler Brook supports founder-led companies by providing growth-focused capital and operational expertise, focusing on scalable Healthcare and B2B models rather than broad venture plays.[2][4] With a fund launched in December 2024, the firm positions itself as a hands-on partner for businesses poised for expansion.[4]
Ambler Brook emerged from the combined expertise of its founding partners, who bring extensive private equity backgrounds from leading firms.[1] Key partners include J. Kearney Shanahan and Stephen Sahlman, both Managing Partners based in Boston, United States.[4] The firm's evolution reflects a sharpened focus on thesis-oriented investments in founder-owned Healthcare and B2B businesses, distinguishing it from generalist PE strategies.[1][2]
While exact founding year details are not specified in available sources, the firm's structure and first fund in market as of December 2024 indicate a recent formalization, building on partners' prior three decades of deal experience.[1][4]
Ambler Brook rides the wave of Healthcare digitization and B2B SaaS consolidation, where founder-owned firms seek patient capital amid rising M&A in lower middle-market tech and services.[1][2] Timing aligns with post-2024 economic recovery, favoring PE firms that blend services and technology investments for resilient growth.[4] Market forces like aging populations boosting Healthcare demand and B2B efficiency tools amid AI integration work in its favor.[1]
The firm influences the ecosystem by empowering founders to dominate niches, fostering a bridge between early-stage innovation and scaled enterprises without diluting ownership prematurely.[2]
Ambler Brook is poised to capitalize on its 2024 fundraise, targeting high-conviction deals in Healthcare and B2B amid favorable M&A cycles and tech-services convergence.[4] Trends like AI-driven Healthcare efficiencies and B2B platform consolidation will shape its portfolio, potentially expanding influence through follow-on investments and exits.[1] As partners deploy their network, the firm could evolve into a lower middle-market powerhouse, redefining founder-partner dynamics in growth equity—much like its thesis-driven origins promise for market-leading builders.[1][2]
Ambler has raised $10.7M across 3 funding rounds. Most recently, it raised $7.0M Series A in June 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2020 | $7M Series A | — | Entrepreneur First, Adrien Neel, Idinvest Partners, Kima Ventures, Partech | Announced |
| Feb 7, 2019 | $1.7M Venture Round | — | Louis B, Kima Ventures, Partech | Announced |
| Feb 1, 2019 | $2M Seed | — | Entrepreneur First | Announced |
Key people at Ambler.
